[HTML][HTML] Novel biochemical determinants in the preclinical evaluation of opiates
F Medzihradsky - 1987 - books.google.com
Research in the field of opioid receptors has received major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[引用][C] Novel biochemical determinants in the preclinical evaluation of opiates.
F Medzihradsky - NIDA Research Monograph, 1987 - europepmc.org
Novel biochemical determinants in the preclinical evaluation of opiates. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - researchgate.net
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - scholar.archive.org
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - academia.edu
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[HTML][HTML] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - … of Drug Dependence, 1986: Proceedings of the …, 1987 - books.google.com
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - leopard.tu-braunschweig.de
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - Citeseer
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[PDF][PDF] Novel Biochemical Determinants in the Preclinical Evaluation of Opiates
F Medzihradsky - Problems of Drug Dependence 1986 - archives.nida.nih.gov
Research in the field of opioid receptors has received a major impetus by the identification of
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
ligands with high selectivity toward receptor types, eg, mu (sufentanil, DAGO), kappa (U50 …
[引用][C] Novel biochemical determinants in the preclinical evaluation of opiates
F Medzihradsky - NIDA research monograph, 1987 - pubmed.ncbi.nlm.nih.gov